Work

Finite-course ocrelizumab in relapsing multiple sclerosis: Results of two prospective open-label trials with matched controls

Year: 2025

Type: article

Source: Multiple Sclerosis Journal

DOI: 10.1177/13524585251375350

Authors: Andrea Salazar-Camelo, Lauren Vega, Yasser Fadlallah, Nicole Bou Rjeily, Alexandra Balshi, Bridget Morris, Mahsa Ghajarzadeh, Ellen M Mowry, Emmanuelle Waubant, Bardia Nourbakhsh

Institutions: Johns Hopkins University, University of California, San Francisco

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Multiple Sclerosis Society, Genentech

Awards: G5080800341, G6968769629

OpenAlex ID: W4414357524

FWCI: 2.918

Cites: 30

Cited by: 5

Related to: